Works matching IS 00070963 AND DT 2022 AND VI 187 AND IP 6

Results: 94
    1

    Corrigenda.

    Published in:
    British Journal of Dermatology, 2022, v. 187, n. 6, p. 1082, doi. 10.1111/bjd.21915
    Publication type:
    Article
    2

    Issue Information.

    Published in:
    British Journal of Dermatology, 2022, v. 187, n. 6, p. i, doi. 10.1111/bjd.20511
    Publication type:
    Article
    3

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    4

    Corrigenda.

    Published in:
    2022
    Publication type:
    Correction Notice
    5

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Editor's Choice.

    Published in:
    British Journal of Dermatology, 2022, v. 187, n. 6, p. vi, doi. 10.1111/bjd.21888
    Publication type:
    Article
    30
    31
    32
    33

    Corrigenda.

    Published in:
    2022
    Publication type:
    Correction Notice
    34

    Corrigenda.

    Published in:
    2022
    Publication type:
    Correction Notice
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey.

    Published in:
    British Journal of Dermatology, 2022, v. 187, n. 6, p. 1054, doi. 10.1111/bjd.21852
    By:
    • Wilson, Britney N.;
    • Shah, Rohan;
    • Menzer, Christian;
    • Aleisa, Abdullah;
    • Sun, Mary D.;
    • Kwong, Bernice Y.;
    • Kaffenberger, Ben H.;
    • Seminario‐Vidal, Lucia;
    • Barker, Christopher A.;
    • Stubblefield, Michael D.;
    • Romesser, Paul B.;
    • Fabbrocini, Gabriella;
    • Alam, Murad;
    • Abdulla, Farah;
    • Dulmage, Brittany;
    • Sibaud, Vincent;
    • Anadkat, Milan;
    • Mazer, Jean‐Michel;
    • Parikh, Dhwani;
    • McLellan, Beth
    Publication type:
    Article
    44
    45

    Safety of tralokinumab in adult patients with moderate‐to‐severe atopic dermatitis: pooled analysis of five randomized, double‐blind, placebo‐controlled phase II and phase III trials*.

    Published in:
    British Journal of Dermatology, 2022, v. 187, n. 6, p. 888, doi. 10.1111/bjd.21867
    By:
    • Simpson, Eric L.;
    • Merola, Joseph F.;
    • Silverberg, Jonathan I.;
    • Reich, Kristian;
    • Warren, Richard B.;
    • Staumont‐Sallé, Delphine;
    • Girolomoni, Giampiero;
    • Papp, Kim;
    • de Bruin‐Weller, Marjolein;
    • Thyssen, Jacob P.;
    • Zachariae, Rebecca;
    • Olsen, Christiana K.;
    • Wollenberg, Andreas
    Publication type:
    Article
    46
    47
    48
    49

    Germline intergenic duplications at Xq26.1 underlie Bazex–Dupré–Christol basal cell carcinoma susceptibility syndrome*.

    Published in:
    British Journal of Dermatology, 2022, v. 187, n. 6, p. 948, doi. 10.1111/bjd.21842
    By:
    • Liu, Yanshan;
    • Banka, Siddharth;
    • Huang, Yingzhi;
    • Hardman‐Smart, Jonathan;
    • Pye, Derek;
    • Torrelo, Antonio;
    • Beaman, Glenda M.;
    • Kazanietz, Marcelo G.;
    • Baker, Martin J.;
    • Ferrazzano, Carlo;
    • Shi, Chenfu;
    • Orozco, Gisela;
    • Eyre, Stephen;
    • van Geel, Michel;
    • Bygum, Anette;
    • Fischer, Judith;
    • Miedzybrodzka, Zosia;
    • Abuzahra, Faris;
    • Rübben, Albert;
    • Cuvertino, Sara
    Publication type:
    Article
    50